Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
04 November 2014 11:55
Experts have found that eribulin can extend the lives of women with aggressive forms of breast cancer by several months
Giving breast cancer patients a drug made from sea sponges can extend their lives by several months, according to a new study.
Researchers at the University of Leeds carried out two large-scale trials with more than 1,800 participants who had been diagnosed with metastatic breast cancer.
They found that the drug eribulin extended the women's survival by an average of more than two months.
Women who had advanced triple negative breast cancer - an aggressive form of the disease for which there are few treatment options - benefited the most from the drug, with their lifespans increasing by almost five months.
Those with HER2 negative breast cancer lived more than two months longer when given eribulin, it was found.
Martin Ledwick, head information nurse at Cancer Research UK, described the results as "encouraging" for those women whose cancers no longer respond to conventional treatments.
He said that eribulin is not a cure but an additional option to extend patients' lives - which could be "priceless" for the women and their families. It may give them the option to spend valuable time with their family and friends, or to embark on a holiday with the security provided by specialist travel insurance for cancer patients.
The drug was originally derived from Halichondria okadai, a sea sponge, although it is now produced in laboratories.
Chris Twelves, professor of clinical cancer pharmacology and oncology at the University of Leeds, said the findings show that eribulin can lead to a "substantial improvement" in women's survival rates.
He pointed out that, while the drug was previously only available for women who had undergone several rounds of chemotherapy, the EU has now also approved it for those who have not received as much treatment.
The findings of the study were presented at the National Cancer Research Institute's cancer conference in Liverpool.
20 September 2017
Thousands of Ryanair flights have been cancelled over the next six weeks, as the airline says it "messed up" allocation of its pilots' annual leave.
[more...]
19 September 2017
Manchester's Girlguides are being urged to help the elderly with a new badge incentivising youngsters to tackle senior loneliness.
16 September 2017
Holidaymakers are being evacuated as winds up to 200km per hour hit Central Vietnam, with Typhoon Doksuri damaging houses, roads and infrastructure.
15 September 2017
People in parts of East Anglia are eight times more likely to survive liver disease than Blackpool residents, according to new data by Public Health England (PHE).
14 September 2017
A non-invasive alternative to gastric bypass surgery that helps people with Type 2 diabetes lose weight is being recommended for widespread use by NHS experts.
13 September 2017
Almost half of UK adults travelling to areas at risk of malaria are not covering themselves by taking medication, despite recommendations made by the NHS and world health organisations.
12 September 2017
A new health warning has been issued by scientists in Sweden, suggesting e-cigarettes with nicotine could lead to an increased risk of heart attacks and strokes.
09 September 2017
Researchers have developed a futuristic pen-like device that can tell whether someone has cancer much faster than current technology.
08 September 2017
A staffing crisis in the NHS is seeing cancer patients turned away from their GP surgery and instead visiting A&E, a report has claimed.
07 September 2017
Whether it's binge-watching box-sets, shopping for clothes, chatting to friends or picking up work emails, staying connected is pretty much essential to everyday life.
06 September 2017
Around 1 in 2 GPs do not know that black men have a higher risk of developing prostate cancer, research has suggested.
05 September 2017
Many middle-aged men have hearts in a condition that makes the organ seem older than the men's actual age, a new study has revealed.